JAMP-MEMANTINE DIN 02409895
Health Canada record
| Active ingredient(s) | MEMANTINE HYDROCHLORIDE 10 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06DX01 MEMANTINE |
| Original market date | 03-Feb-2015 |
| Current status date | 07-Dec-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MEMANTINE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02324067 | ACT MEMANTINE | TEVA CANADA LIMITED | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02324059 | ACT MEMANTINE | TEVA CANADA LIMITED | Tablet | MEMANTINE HYDROCHLORIDE 5 MG | Approved |
| 02366487 | APO-MEMANTINE | APOTEX INC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02409887 | JAMP-MEMANTINE | JAMP PHARMA CORPORATION | Tablet | MEMANTINE HYDROCHLORIDE 5 MG | Approved |
| 02446049 | MEMANTINE | SIVEM PHARMACEUTICALS ULC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02443082 | MEMANTINE | SANIS HEALTH INC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02425742 | MEMANTINE HYDROCHLORIDE TABLETS | ALEMBIC PHARMACEUTICALS LIMITED | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Approved |
| 02531887 | MINT-MEMANTINE | MINT PHARMACEUTICALS INC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02382830 | PMS-MEMANTINE | PHARMASCIENCE INC | Tablet | MEMANTINE HYDROCHLORIDE 5.0 MG | Marketed |
| 02321130 | PMS-MEMANTINE | PHARMASCIENCE INC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02348950 | RIVA-MEMANTINE | LABORATOIRE RIVA INC. | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02375532 | SANDOZ MEMANTINE FCT | SANDOZ CANADA INCORPORATED | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Marketed |
| 02260638 | EBIXA | LUNDBECK CANADA INC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02349116 | MEMANTINE | MELIAPHARM INC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02430371 | MYLAN-MEMANTINE | MYLAN PHARMACEUTICALS ULC | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02321599 | NOVO-MEMANTINE | TEVA CANADA LIMITED | Tablet | MEMANTINE HYDROCHLORIDE 5 MG | Cancelled Pre Market |
| 02321602 | NOVO-MEMANTINE | TEVA CANADA LIMITED | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Pre Market |
| 02421364 | RAN-MEMANTINE | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02320908 | RATIO-MEMANTINE | TEVA CANADA LIMITED | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
| 02344807 | SANDOZ MEMANTINE | SANDOZ CANADA INCORPORATED | Tablet | MEMANTINE HYDROCHLORIDE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 27179 | 2021-12-07 | Abbreviated New Drug Submission (ANDS) | Administrative: Change in Product Ownership |
| 14685 | 2013-08-27 | Abbreviated New Drug Submission (ANDS) |
International API supply for MEMANTINE HYDROCHLORIDE
6 valid EDQM Certificates of Suitability from 6 holders. 29 active FDA Drug Master Files.
Request a quote for JAMP-MEMANTINE